Evolution of treatment for acute myelogenous leukemia and myelodysplastic syndrome at M.D. Anderson Cancer Center 1985-1991.
Keating
M J
MJ
University of Texas M.D. Anderson Cancer Center, Houston.
Estey
E
E
Kantarjian
H
H
Plunkett
W
W
O'Brien
S
S
Koller
C
C
Beran
M
M
Freireich
E J
EJ
D000677:Amsacrine / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives
D000677:Amsacrine; D003561:Cytarabine; D014740:Vidarabine; C024352:fludarabine; D015255:Idarubicin; D003630:Daunorubicin